Solventum Corp SOLV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SOLV is a good fit for your portfolio.
News
-
Solventum Announces First Quarter 2024 Earnings Release Date and Upcoming Investor Events
-
Solventum Names Shirley Edwards to Board of Directors
-
3M's $12.5 billion settlement to address 'forever chemicals' in drinking water receives final court approval
-
Solventum Begins Trading on the New York Stock Exchange
-
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
-
GE Vernova, Solventum to join S&P 500 index next week
-
Solventum Hosts Inaugural Investor Day Ahead of Its Planned Spinoff from 3M
-
3M Board of Directors Approves Spin-off of Solventum
Trading Information
- Previous Close Price
- $64.43
- Day Range
- $63.04–66.67
- 52-Week Range
- $60.72–96.05
- Bid/Ask
- $65.48 / $66.38
- Market Cap
- $11.38 Bil
- Volume/Avg
- 2.2 Mil / 3.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.45
- Price/Sales
- 1.35
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Solventum is an independent healthcare company with a primary focus on solving big healthcare challenges. Its diverse product portfolio spans across the healthcare industry from medical solutions and oral care to health information systems and separation and purification sciences.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Mid Growth
- Total Number of Employees
- —
- Website
- https://www.3m.com
Valuation
|
Metric
|
SOLV
|
|---|---|
Price/Earnings (Normalized) | 10.45 |
Price/Book Value | — |
Price/Sales | 1.35 |
Price/Cash Flow | 6.21 |
Price/Earnings
SOLV
Financial Strength
|
Metric
|
SOLV
|
|---|---|
Quick Ratio | 1.07 |
Current Ratio | 1.65 |
Interest Coverage | — |
Quick Ratio
SOLV
Profitability
|
Metric
|
SOLV
|
|---|---|
Return on Assets (Normalized) | 4.83% |
Return on Equity (Normalized) | 12.13% |
Return on Invested Capital (Normalized) | 5.73% |
Return on Assets
SOLV
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Xdcdsh | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Fhdgcsxww | Yjg | $32.4 Bil | |
MTHRF
| M3 Inc | — | Phxzdyh | $8.2 Bil | |
MTHRY
| M3 Inc ADR | — | Jxpddz | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Wvvbfcf | $7.5 Bil | |
HQY
| HealthEquity Inc | — | Jvswnq | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Xpncg | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Jhyqnss | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Dby | $3.3 Bil |